These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10083268)

  • 1. Blockade of CD40L/CD40 costimulatory pathway in a DST presensitization model of islet allograft leads to a state of Allo-Ag specific tolerance and permits subsequent engraftment of donor strain islet or heart allografts.
    Zheng XX; Li Y; Li XC; Roy-Chaudhury P; Nickerson P; Tian Y; Sayegh MH; Strom TB
    Transplant Proc; 1999; 31(1-2):627-8. PubMed ID: 10083268
    [No Abstract]   [Full Text] [Related]  

  • 2. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment.
    Zheng XX; Markees TG; Hancock WW; Li Y; Greiner DL; Li XC; Mordes JP; Sayegh MH; Rossini AA; Strom TB
    J Immunol; 1999 Apr; 162(8):4983-90. PubMed ID: 10202046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complement dependent cytotoxicity (CDC) immune effector mechanism contributes to anti-CD154 induced immunosuppression.
    Sánchez-Fueyo A; Domenig C; Strom TB; Zheng XX
    Transplantation; 2002 Sep; 74(6):898-900. PubMed ID: 12364878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of CD40-mediated signaling is sufficient for inducing islet but not skin transplantation tolerance.
    Phillips NE; Markees TG; Mordes JP; Greiner DL; Rossini AA
    J Immunol; 2003 Mar; 170(6):3015-23. PubMed ID: 12626555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of immunological tolerance to islet allografts.
    Rossini AA; Parker DC; Phillips NE; Durie FH; Noelle RJ; Mordes JP; Greiner DL
    Cell Transplant; 1996; 5(1):49-52. PubMed ID: 8665076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
    Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
    Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged anti-CD40 ligand therapy improves primate cardiac allograft survival.
    Chang AC; Blum MG; Blair KS; Scott MA; Brock JE; Thomas DW; Burkly LC; Miller GG; Pierson RN
    Transplant Proc; 1999; 31(1-2):95. PubMed ID: 10083025
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
    Iwakoshi NN; Mordes JP; Markees TG; Phillips NE; Rossini AA; Greiner DL
    J Immunol; 2000 Jan; 164(1):512-21. PubMed ID: 10605049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival.
    Rastellini C; Salam A; Kuddus R; Aitouche A; Subbotin V; Braun M; Leach R; Peach R; Fung JJ; Starzl TE; Rao AS
    Transplant Proc; 1999; 31(1-2):1242-3. PubMed ID: 10083554
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of islet transplantation tolerance using donor specific transfusion and anti-CD154 monoclonal antibody.
    Rossini AA; Mordes JP; Markees TG; Phillips NE; Gordon EJ; Greiner DL
    Transplant Proc; 1999; 31(1-2):629-32. PubMed ID: 10083269
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Operational tolerance induced by pretreatment with donor dendritic cells under blockade of CD40 pathway.
    Niimi M; Shirasugi N; Ikeda Y; Kan S; Takami H; Hamano K
    Transplantation; 2001 Nov; 72(9):1556-62. PubMed ID: 11707745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD40-CD40 ligand-independent activation of CD8+ T cells can trigger allograft rejection.
    Jones ND; Van Maurik A; Hara M; Spriewald BM; Witzke O; Morris PJ; Wood KJ
    J Immunol; 2000 Jul; 165(2):1111-8. PubMed ID: 10878390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of both donor and recipient strains on cardiac allograft survival after blockade of the CD40-CD154 costimulatory pathway.
    van Maurik A; Wood KJ; Jones ND
    Transplantation; 2002 Sep; 74(5):740-3. PubMed ID: 12352896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance to islet xenografts induced by dual manipulation of antigen presentation and co-stimulation.
    Markees TG; Appel MC; Noelle RJ; Mordes JP; Greiner DL; Rossini AA
    Transplant Proc; 1996 Apr; 28(2):814-5. PubMed ID: 8623413
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation of skin and islet allograft survival in mice treated with costimulation blockade is mediated by different CD4+ cell subsets and different mechanisms.
    Banuelos SJ; Markees TG; Phillips NE; Appel MC; Cuthbert A; Leif J; Mordes JP; Shultz LD; Rossini AA; Greiner DL
    Transplantation; 2004 Sep; 78(5):660-7. PubMed ID: 15371665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of the PD-1/PD-1L pathway reverses the protective effect of anti-CD40L therapy in a rat to mouse concordant islet xenotransplantation model.
    Mai G; del Rio ML; Tian J; Ramirez P; Buhler L; Rodriguez-Barbosa JI
    Xenotransplantation; 2007 May; 14(3):243-8. PubMed ID: 17489865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation tolerance to rat cardiac and islet allografts by posttransplant intrathymic inoculation of soluble alloantigens.
    Ohajekwe OA; Chowdhury NC; Fiedor PS; Hardy MA; Oluwole SF
    Transplantation; 1995 Nov; 60(10):1139-43. PubMed ID: 7482722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejection.
    Guillot C; Guillonneau C; Mathieu P; Gerdes CA; Ménoret S; Braudeau C; Tesson L; Renaudin K; Castro MG; Löwenstein PR; Anegon I
    J Immunol; 2002 Feb; 168(4):1600-9. PubMed ID: 11823487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.